Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: Technical considerations and clinical feasibility

Magnetic Resonance in Medicine

Volumn 63, Issue 4, 2010, Pages 951-958

  Edelman, Robert R ^a   Sheehan, John J ^a   Dunkle, Eugene ^a   Schindler, Nancy ^a   Carr, James ^b   Koktzoglou, Ioannis ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Flow; Magnetic resonance angiography unenhanced; Peripheral vascular disease; Steady state precession; Two dimensional

Indexed keywords

ANGIOGRAPHY; TWO DIMENSIONAL;

CLINICAL FEASIBILITY; CONTRAST-ENHANCED MR; FLOW; MAGNETIC RESONANCE ANGIOGRAPHY; NEGATIVE PREDICTIVE VALUE; PERIPHERAL VASCULAR DISEASE; STEADY STATE; TECHNICAL OPTIMIZATION;

MAGNETIC RESONANCE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEASIBILITY STUDY; HUMAN; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PELVIS; PERIPHERAL VASCULAR DISEASE; PILOT STUDY; SENSITIVITY AND SPECIFICITY; STEADY STATE;

EID: 77950611658     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22287     Document Type: Article

References (17)

1. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-515.
2. Hiatt WR. Medical treatment of peripheral arterial disease and claudications. N Engl J Med 2001;344:1608-1621.
3. Ersoy H, Rybicki FJ. MR angiography of the lower extremities. AJR Am J Roentgenol 2008;190:1675-1684.
4. Guerrero A, Montes R, Munoz-Terol J, et al. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant 2006;21:3525-3531.
5. Kuo PH, Kanal E, Abu-Alfa AK, et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242: 647-649.
6. Kaufman JA, McCarter D, Geller SC, Waltman AC. Two-dimensional time-of-flight MR angiography of the lower extremities: artifacts and pitfalls. AJR Am J Roentgenol 1998;171:129-135.
7. Owen RS, Carpenter JP, Baum RA, Perloff LJ, Cope C. Magnetic resonance imaging of angiographically occult runoff vessels in peripheral arterial occlusive disease. N Engl J Med 1992;326:1577-1581.
8. McCauley TR, Monib A, Dickey KW, Clemett J, Meier GH, Egglin TK, Gusberg RJ, Rosenblatt M, Pollak JS. Peripheral vascular occlusive disease: accuracy and reliability of time-of-flight MR angiography. Radiology 1994;192:351-357.
9. Miyazaki M, Takai H, Sugiura S, Wada H, Kuwahara R, Urata J. Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered threedimensional half-Fourier fast spin-echo imaging. Radiology 2003;227: 890-896.
10. Nakamura K, et al. Fresh blood imaging (FBI) of peripheral arteries: comparison with 16-detector row CT angiography. Proc Int Soc Magn Reson Med 2006;14:1929.
11. Lim RP et al. 3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging 2008;28:181-189.
12. Fuchs F, Laub G, Othomo K. TrueFISP-technical considerations and cardiovascular applications. Eur J Radiol 2003;46:28-32.
13. Korosec FR, Frayne R, Grist TM, Mistretta CA. Time-resolved contrastenhanced 3D MR angiography. Magn Reson Med 1996;36:345-51.
14. Wright GA, Nishimura DG, Macovski A. Flow-independent magnetic resonance projection angiography. Magn Reson Med 1991;17: 126-140.
15. Edelman RR, Koktzoglou I. Unenhanced flow-independent MR venography by using signal targeting alternative radiofrequency and flow independent relaxation enhancement. Radiology 2009;250: 236-245.
16. Deimling M, Heid O. Magnetization prepared true FISP imaging. In: Proceedings of the Second Annual Meeting of the Society of Magnetic Resonance, San Francisco, 1994. p 495.
17. Scheffler K, Lehnhardt S. Principles and applications of balanced SSFP techniques. Eur Radiol 2003;13:2409-2418.